IL Dong Pharmaceutical
일동제약 · 249420
Health Care Pharmaceuticals · KOSPI
Market cap US$465.4M (₩642.3B)
Overview
IL Dong Pharmaceutical makes prescription medicines, active-vitamin supplements (sold under the Aronamin brand), antibiotics, health supplements, and specialty nutritional foods for patients and consumers in South Korea.
Its products reach end users through the domestic healthcare and retail supply chain. Listed on KOSPI, South Korea's main stock exchange, the company's product range is anchored by its active-vitamin Aronamin line and the antibiotic Flumarin, which together represent its core manufactured goods.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$435.3M
- FY2024US$445.6M
- FY2025US$410.8M
Operating profit
- FY2023−US$39.1M
- FY2024US$9.5M
- FY2025US$14.1M
Net income
- FY2023−US$58.7M
- FY2024−US$9M
- FY2025US$17.2M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?